Pricing Log in Create free account

Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY) vs Indaptus Therapeutics, Inc. (INDP)

Ceryvyn Therapeutics Ltd. - Unsponsored ADR and Indaptus Therapeutics, Inc. are both Biotechnology companies. Ceryvyn Therapeutics Ltd. - Unsponsored ADR and Indaptus Therapeutics, Inc. are of similar size ($524.8M and $497.6M). Indaptus Therapeutics, Inc. has the higher net margin (0.00% vs −89,724.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Ceryvyn Therapeutics Ltd. - Unsponsored ADR leads on 4 and Indaptus Therapeutics, Inc. on 4.

Valuation

Metric CYVNY INDP Biotechnology median
P/E n/m n/m 10.64
P/S 2.37 n/m 9.59
P/B n/m 33.39 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales 759.28 n/m 9.45
Earnings yield (2,375.00%) (236.87%) (34.69%)
Free cash flow yield (84,379.36%) (3.87%) (24.02%)

Profitability

Metric CYVNY INDP Biotechnology median
Gross margin 0.00% 0.00% 65.59%
Operating margin 0.00% 0.00% 0.00%
Net margin (89,724.18%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (318.04%) (51.96%)
Return on assets 0.00% (163.84%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYVNY INDP Biotechnology median
Revenue growth (TTM) — — 4.59%
EPS growth (last fiscal year) 61.59% 52.15% 29.88%
Revenue growth, 5-year CAGR (15.81%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYVNY INDP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.22 19.48 4.86
Net debt to EBITDA 0.31 0.43 1.01

Dividend

Metric CYVNY INDP Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric CYVNY INDP Biotechnology median
Market cap 524.83m 497.60m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack